Last edition
News about Market
Biocon Raises INR 4,150 Crore via QIP
Biocon has successfully raised INR 4,150 crore through a Qualified Institutions Placement (QIP), with the proceeds set to be primarily used to fund the cash consideration payable to Mylan Inc. (Viatris) for the buyout of its stake in Biocon Biologics, including the repayment of related acquisition debt.
Market | 15/01/2026 | By News Bureau | 133
Genethon Partners with AskBio on Pompe Gene Therapy
The licensing deal enables AskBio to advance the clinical development of Genethon’s investigational gene therapy for Pompe disease through an industry partnership.
Market | 15/01/2026 | By News Bureau | 134
Amneal Unveils New Brand to Expand Access to Medicines
The refreshed brand features a new visual identity and “Signature” logo that reflects trust in healthcare, patient impact, and Amneal’s focus on expanding access to medicines across complex therapeutic areas.
Market | 15/01/2026 | By News Bureau | 211
Dr Reddy's Launches First-to-Market Olopatadine Ophthalmic Solution in US
With the US launch of its first-to-market OTC Olopatadine 0.7 percent eye drops, Dr Reddy’s expands access to allergy relief for itchy eyes caused by pollen and other common allergens.
Market | 15/01/2026 | By News Bureau | 141
Bayer to Enter Molecular Imaging, Acquires Pan-Amyloid Radiotracers from Attralus
By acquiring AT-01 and AT-05 from Attralus, Bayer strengthens its molecular imaging and cardiovascular precision medicine portfolio, targeting earlier and more accurate diagnosis of amyloidosis.
Market | 14/01/2026 | By News Bureau | 212
Thermo Fisher and NVIDIA Partner to Advance AI-Driven Scientific Instrumentation
Under the partnership, Thermo Fisher Scientific and NVIDIA will connect laboratory instruments and data systems with advanced AI capabilities to streamline operations and accelerate scientific research.
Market | 14/01/2026 | By News Bureau | 148
EQT Life Sciences Exits Vivasure Medical Following Sale to Haemonetics
EQT Life Sciences, formerly known as LSP, one of Europe’s largest life sciences investors, has announced that its LSP Health Economics Fund has exited Vivasure Medical Limited, a Galway-based medical device company, following its acquisition by Haemonetics Corporation, a global medical technology company.
Market | 13/01/2026 | By Darshana | 191
West Pharmaceutical Services has entered a definitive agreement to divest the manufacturing and supply rights of its SmartDose 3.5mL On-Body Delivery System to AbbVie, as part of a strategic portfolio review, with the transaction expected to close in mid-2026.
Market | 13/01/2026 | By News Bureau | 279
Merck Explores USD 28-32 Billion Buyout of Oncology Biotech Revolution Medicines
Merck & Co. is in discussions to acquire U.S.-based oncology biotech Revolution Medicines in a deal that could value the company between USD 28 billion and USD 32 billion, according to people familiar with the matter.
Market | 11/01/2026 | By Darshana | 310
MediLink, Roche Sign Global Licensing Deal for YL201 ADC Therapy
Agreement includes USD 570 million upfront and milestones to advance B7H3-targeting solid tumor cancer treatment worldwide.
Market | 09/01/2026 | By News Bureau | 444
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy